The HKAPI Basketball Tournament 2018-19 has finally come to an end on August 22 2019. The tournament has not only given our colleagues a chance to unite their team and boost their team morale, but also allowed us to know more about our peers from the industry from another perspective.
45 people showed up at the last episode of the Precision Medicine Series. This episode centered on the status quo and challenges faced by the industry and the regulator from the regulatory and legal perspective, worldwide and in Hong Kong, as the trend of precision medicine arrives.
This was the third seminar jointly organized by The University of Hong Kong, The University of Macau as well as the Pharmaceutical Society of Macao, supported and sponsored by the HKAPI.
Attended by about 50 members, Part 2 of the “Precision Medicine Seminar Series” was an intensive panel discussion centered on discussing the opportunities and challenges of commercialization of precision medicine as well as its commercial applications.
Organized by the HKAPI R&D Ecosystem Taskforce and supported by Baker McKenzie, the first seminar of the “Precision Medicine Seminar Series” was attended by around 50 members at Baker McKenzie’s new office in Quarry Bay.
To share findings from a recently conducted Patient Support Program research and to build a platform for stakeholders to exchange point of view, the HKAPI organized a sharing session for member companies and their collaborating partners on May 17, 2019.
On 8 May 2019, a total of 42 participants from the HKAPI, InvestHK and Hong Kong Science Park attended the “Why Invest in Hong Kong” Seminar held at the Baker McKenzie Office in Quarry Bay.
On May 2, 2019, nearly 30 members of 13 companies, including senior management and marketers, joined the Phase 2 workshop of Pharma-Insurance Collaboration.
On 30 April 2019, the Regulatory Affairs Taskforce (RATF) presented a sharing session to update members on the latest achievements and work in progress in relation to the various regulatory affairs initiatives.